Stakeboat Capital is a Bengaluru-based private equity firm that plays a different game from most venture investors in India: it takes control or co-control positions in small and medium enterprises, acting as a long-horizon operating partner rather than a minority cheque-writer. Launched in 2016 by serial healthcare entrepreneur GSK Velu, it targets the lower end of the mid-market, partnering with founders who have built real, revenue-generating businesses and helping professionalise them for scale and exit.
The firm's strategy has two layers. First, it identifies asset-light companies in high-growth sectors with distinctive competitive advantages. Typically the firm stays invested for three to five years before exiting via a strategic or secondary sale.
Investment thesis and focus
Stakeboat manages assets across two business segments and three focus sectors: healthcare, lifesciences and pharma; value-added industrials and manufacturing; and B2B technologies and business services, per its own website. The firm describes itself as value-oriented, backing passionate entrepreneurs with scalable business models and adding value to companies and communities.
Its deal profile is precise: companies with revenue between Rs 50 crore and Rs 250 crore, in which it takes 51-70 percent equity through control, co-control and buyout transactions, both primary and secondary. Exit horizon is typically three to five years. Founder and managing partner Chandrasekar Kandasamy told VCCircle the strategy is to support SME entrepreneurs 'in multiple ways, be it in monetising their business or bringing in global connects and relationships'.
Fund and stage
Stakeboat's debut fund was launched alongside a family office managing Velu's private investments, with Velu anchoring $20 million of a vehicle that originally targeted Rs 500 crore (later reduced). It marked a first close of Rs 210 crore (about $33 million) in early 2018 and had raised Rs 270-280 crore by December 2018, according to VCCircle.
The second fund, launched in January 2021, sought to raise Rs 1,000 crore (about $136 million), with SEBI approval received in November 2020. The firm said it would open the fund to domestic and international investors, expecting a large part to come from institutional investors and family offices. Note the structure: this is growth-stage private equity with control positions, not seed or Series A venture capital.
Portfolio highlights
Stakeboat's investments, tracked by Inc42, include enterprise SaaS unicorn LeadSquared, where it invested $3 million in 2019; cloud contact-centre platform Ozonetel Communications, in which it led the $4.95 million Series A in 2021; microfinance institution Dvara KGFS ($14 million, 2019); DiFACTO Robotics and Automation ($4.8 million, May 2024); Sukino (continued-care health tech); semiconductor services firm Sankalp Semiconductor; Leixir Group; and healthcare chain Kauvery.
People and how to reach them
The firm is led by founder and managing partner Chandrasekar Kandasamy, a private equity veteran previously associated with Carlyle and ICICI Venture, alongside A. Ganesan. Its website lists managing directors Srinivas Baratam, Girish Patil and Deepti Malik, plus a wider team of vice presidents and associates. Stakeboat's own materials claim its members bring 150+ man-years of experience with more than 100 investments creating $8+ billion of value.
Why it matters for founders
Stakeboat Capital matters for a specific founder profile: an SME doing Rs 50-250 crore in revenue in healthcare, manufacturing or B2B services, and willing to sell a 51-70 percent controlling stake to an operator-led partner. It is not for pre-revenue or venture-stage startups. But for profitable mid-market companies ready to professionalise and scale, its control-buyout model and healthcare-industrial network are hard to replicate.